| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/03/2003 | WO2003026663A1 Process for making substituted pyrazoles |
| 04/03/2003 | WO2003026648A1 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
| 04/03/2003 | WO2003026647A1 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 04/03/2003 | WO2003026579A2 Combination therapies for immune mediated diseases |
| 04/03/2003 | WO2003026420A1 Bactericidal solutions |
| 04/03/2003 | WO2003006104A3 Lymphatic endothelial cells materials and methods |
| 04/03/2003 | WO2002086078A3 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 04/03/2003 | WO2002081424A3 Chemical compounds derived from octopamine and their uses as beta 3-adrenergic agonists |
| 04/03/2003 | WO2002076460A3 Use of propentofylline to control intraocular pressure |
| 04/03/2003 | WO2002074230A3 A dna molecule encoding a variant paraoxonase and uses thereof |
| 04/03/2003 | WO2002057413A3 Peptides for activation and inhibition of delta pkc |
| 04/03/2003 | WO2002039954A3 Novel compounds |
| 04/03/2003 | WO2002022166A9 Tweak receptor agonists as anti-angiogenic agents |
| 04/03/2003 | WO2002014369A9 Human kininogen d5 domain polypeptides and their use |
| 04/03/2003 | WO2002007731A3 Composition containing a 15-keto prostaglandin compound for treating of ocular hypertension and glaucoma |
| 04/03/2003 | WO2002000860A3 Novel proteases |
| 04/03/2003 | WO2001072782A9 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 04/03/2003 | US20030065174 Antiinflammatory agents; analgesics |
| 04/03/2003 | US20030064996 Anticarcinogenic agents, antiinflammatory agents, anticholesterol agents, antidiabetic agents |
| 04/03/2003 | US20030064992 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/03/2003 | US20030064987 Immunology moderators; interleukin antagonist; anticancer agents |
| 04/03/2003 | US20030064983 Headaches; antiarthritic agents; respiratory system disorders; psychological disorders |
| 04/03/2003 | US20030064952 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 04/03/2003 | US20030064942 Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS) |
| 04/03/2003 | US20030064935 Amino acid complexes of C-aryl glucosides for treatment of diabetes and method |
| 04/03/2003 | US20030064919 Novel polypeptides and polynucleotides encoding same |
| 04/03/2003 | US20030064410 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 04/03/2003 | US20030064098 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/03/2003 | US20030064088 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion |
| 04/03/2003 | US20030064069 Specific binding members for TGFbeta1 |
| 04/03/2003 | CA2461666A1 Combination therapies for immune mediated diseases |
| 04/03/2003 | CA2461372A1 Dna sequences for human angiogenesis genes |
| 04/03/2003 | CA2461095A1 Process for making substituted pyrazoles |
| 04/03/2003 | CA2460953A1 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | CA2460000A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 04/03/2003 | CA2455910A1 Ophthalmologic treatment methods using selective inos inhibitors |
| 04/02/2003 | EP1297849A1 Remedial agent for optic nerve disease and the like |
| 04/02/2003 | EP1297838A1 Pralmorelin-containing nasal drop preparations |
| 04/02/2003 | EP1297837A1 Remedies for allergic diseases and process for producing the same |
| 04/02/2003 | EP1297833A1 Indole carboxylic acids as thyroid receptor ligands |
| 04/02/2003 | EP1297014A2 Transporters and ion channels |
| 04/02/2003 | EP1296996A1 Purine derivatives |
| 04/02/2003 | EP1296990A2 Dihydropyridine compounds for the inhibition of calcium-influx |
| 04/02/2003 | EP1296976A1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 04/02/2003 | EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/02/2003 | EP1296961A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 04/02/2003 | EP1296949A2 Piperidine amides as modulators of chemokine receptor activity |
| 04/02/2003 | EP1296946A1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 04/02/2003 | EP1296943A1 Amino acid derivatives and their use as medicines |
| 04/02/2003 | EP1296936A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/02/2003 | EP1296934A1 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists |
| 04/02/2003 | EP1296929A2 Modified forms of pharmacologically active agents and uses therefor |
| 04/02/2003 | EP1296923A2 Aspirin-triggered lipid mediators |
| 04/02/2003 | EP1296705A1 Neurotoxic oligomers |
| 04/02/2003 | EP1296670A1 Therapeutic combinations of fatty acids |
| 04/02/2003 | EP1296645A2 Methods for treating inflammation-mediated conditions of the eye |
| 04/02/2003 | EP1296552A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 04/02/2003 | EP1246627A4 Polyanhydrides with biologically active degradation products |
| 04/02/2003 | EP1135126A4 Myt1 kinase inhibitors |
| 04/02/2003 | EP0954519B1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 04/02/2003 | EP0873295B1 Dimer-selective rxr modulators and methods for their use |
| 04/02/2003 | CN1407993A Gene recombinant antibody and its fragment |
| 04/02/2003 | CN1407990A C-aryl glucoside sgltz inhibitors |
| 04/02/2003 | CN1407985A Heterocyclic dihydropyrimidine as potassium path inhibitor |
| 04/02/2003 | CN1407980A Heterocyclic derivatives |
| 04/02/2003 | CN1407970A Urea compounds having muscarinic receptor antagonist activity |
| 04/02/2003 | CN1407903A Concomitant drugs for treating glaucoma |
| 04/02/2003 | CN1406629A Vaccin of heterogenous blood vessel endothetial cell growth factor and preparing process thereof |
| 04/02/2003 | CN1406610A Eye drop with various herb medicines and preparation thereof |
| 04/02/2003 | CN1406604A Chinese medicine for treating eye diseases |
| 04/02/2003 | CN1406599A Process for producing medicine or health-care food from abalone shells |
| 04/02/2003 | CN1406586A Eye drop containing diuridine phosphoric acid |
| 04/02/2003 | CN1104422C Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 04/02/2003 | CN1104421C Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/02/2003 | CN1104235C Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541638 (2S,4S)-1-(4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carbonyl)-piperidine-4-carboxylic acid ethyl ester for example; zinc protease inhibitors; for treating diseases associated with vasoconstriction |
| 04/01/2003 | US6541616 Exterior membrane; nucleotide sequence; induction immunology response |
| 04/01/2003 | US6541503 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/2003 | US6541490 Treating ischemia or reoxygenation injury; preparation from a bipyridine, a benzeneboronic acid and a manganese salt |
| 04/01/2003 | US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1 |
| 04/01/2003 | US6541485 Urea substituted imidazoquinolines |
| 04/01/2003 | US6540990 Topical application to the eye of an acetylcholine esterase inhibitor, such as a mercaptoethyltrimethylammonium salt, to improve visual acuity |
| 03/31/2003 | WO2002030425A1 Preventives and remedies for complications of diabetes |
| 03/31/2003 | CA2424060A1 Preventives and remedies for complications of diabetes |
| 03/28/2003 | WO2002030871A1 Use of amino acids for treating pain |
| 03/28/2003 | CA2424089A1 Use of amino acids for treating pain |
| 03/27/2003 | WO2003025542A2 Immune response associated proteins |
| 03/27/2003 | WO2003025199A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor |
| 03/27/2003 | WO2003025155A1 Fermentation product of cyptoporus volvatus and its preparation method and use |
| 03/27/2003 | WO2003025140A2 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 03/27/2003 | WO2003024993A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 03/27/2003 | WO2003024966A1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 03/27/2003 | WO2003024948A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists |
| 03/27/2003 | WO2003024922A1 Hydroxyfattysulfonic acid analogs |
| 03/27/2003 | WO2003024528A1 Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment for ocular infections |
| 03/27/2003 | WO2003024453A1 Excitatory amino acid receptor antagonists |
| 03/27/2003 | WO2003024420A1 Ophthalmic depot formulations for periocular or subconjunctival administration |
| 03/27/2003 | WO2003024390A2 Hydroxyeicosenoic acid analogs |
| 03/27/2003 | WO2002096318A3 Method for treating glaucoma v |